These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26998897)

  • 1. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas.
    Ota R; Sawada T; Tsuyama S; Sasaki Y; Suzuki H; Kaizaki Y; Hasatani K; Yamamoto E; Nakanishi H; Inagaki S; Tsuji S; Yoshida N; Doyama H; Minato H; Nakamura K; Kasashima S; Kubota E; Kataoka H; Tokino T; Yao T; Minamoto T
    J Pathol; 2020 Nov; 252(3):330-342. PubMed ID: 32770675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
    Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
    Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight into the genetic pathway of adenocarcinoma of the small intestine.
    Wheeler JM; Warren BF; Mortensen NJ; Kim HC; Biddolph SC; Elia G; Beck NE; Williams GT; Shepherd NA; Bateman AC; Bodmer WF
    Gut; 2002 Feb; 50(2):218-23. PubMed ID: 11788563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
    Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
    Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations.
    Mafficini A; Amato E; Cataldo I; Rusev BC; Bertoncello L; Corbo V; Simbolo M; Luchini C; Fassan M; Cantù C; Salvia R; Marchegiani G; Tortora G; Lawlor RT; Bassi C; Scarpa A
    Ann Surg; 2018 Jan; 267(1):149-156. PubMed ID: 27611608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of marker genes and pathways specific to precancerous duodenal adenomas and early stage adenocarcinomas.
    Sakaguchi Y; Yamamichi N; Tomida S; Takeuchi C; Kageyama-Yahara N; Takahashi Y; Shiogama K; Inada KI; Ichinose M; Fujishiro M; Koike K
    J Gastroenterol; 2019 Feb; 54(2):131-140. PubMed ID: 29951927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
    Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
    Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing.
    Intarajak T; Udomchaiprasertkul W; Bunyoo C; Yimnoon J; Soonklang K; Wiriyaukaradecha K; Lamlertthon W; Sricharunrat T; Chaiwiriyawong W; Siriphongpreeda B; Sutheeworapong S; Kusonmano K; Kittichotirat W; Thammarongtham C; Jenjaroenpun P; Wongsurawat T; Nookaew I; Auewarakul C; Cheevadhanarak S
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL; Chen YT; Yantiss RK
    Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
    Hänninen UA; Katainen R; Tanskanen T; Plaketti RM; Laine R; Hamberg J; Ristimäki A; Pukkala E; Taipale M; Mecklin JP; Forsström LM; Pitkänen E; Palin K; Välimäki N; Mäkinen N; Aaltonen LA
    PLoS Genet; 2018 Mar; 14(3):e1007200. PubMed ID: 29522538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
    Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
    Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
    Santana NO; Lerario AM; Schmerling CK; Marui S; Alves VAF; Hoff AO; Kopp P; Danilovic DLS
    Eur J Endocrinol; 2020 Dec; 183(6):647-656. PubMed ID: 33120354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.